Share Consolidation Effective Total Voting Rights

By

Regulatory News | 03 May, 2022

Updated : 08:03

RNS Number : 0657K
Tate & Lyle PLC
03 May 2022
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION.

 

FOR IMMEDIATE RELEASE

 

3 May 2022

Tate & Lyle PLC

("Tate & Lyle")

 

Share Consolidation Effective and Total Voting Rights

 

Further to the announcement made by Tate & Lyle on 26 April 2022 that shareholder approval was granted at the General Meeting for the Special Dividend and associated Share Consolidation, Tate & Lyle is pleased to announce that the Share Consolidation has today become effective.

 

Admission of Tate & Lyle's New Ordinary Shares to the premium listing segment of the Official List of the Financial Conduct Authority and to trading on the London Stock Exchange's Main Market for listed securities took place at 8.00 a.m. today.

 

The ISIN for the New Ordinary Shares is GB00BP92CJ43.

 

As a result of the Share Consolidation and in accordance with the requirements of the FCA's Disclosure Guidance and Transparency Rule 5.6.1A, Tate & Lyle's issued share capital as at 8.00 a.m. on 3 May 2022 consisted of 401,603,808 ordinary shares of 291/6 pence each and 2,394,000 preference shares of £1.00 each, which have limited voting rights. Tate & Lyle does not hold any shares in treasury. Therefore, the total number of shares with full voting rights in Tate & Lyle as at 8.00 a.m. on 3 May 2022 was 401,603,808.

 

The above figure may be used by shareholders and others with notification obligations as their denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, Tate & Lyle under the FCA's Disclosure Guidance and Transparency Rules.

 

Capitalised terms used but not otherwise defined in this Announcement have the same meaning given to them in the shareholder circular dated 7 April 2022.

 

For more information contact:

 

For Tate & Lyle PLC

 

Investors and analysts

Christopher Marsh, VP Investor Relations

Tel: Mobile: +44 (0) 7796 192 688

 

Media

Nick Hasell, FTI Consulting

Tel: Mobile: +44 (0) 7825 523 383

 

Information on Tate & Lyle

 

Tate & Lyle is a leading global provider of food and beverage ingredients and solutions. Supported by our 160-year history of ingredient innovation, we partner with customers to provide consumers with healthier and tastier choices when they eat and drink. We are proud that millions of people around the world consume products containing our ingredients every day.

 

Through our expertise in sweetening, mouthfeel and fibre fortification, we develop solutions which reduce sugar, calories and fat, add fibre, and provide texture and stability in categories including beverages, dairy, bakery, soups, sauces and dressings.

 

We have more than 3,000 employees working in around 60 locations across 30 countries. Tate & Lyle's purpose is Transforming Lives Through the Science of Food and through our purpose we believe we can successfully grow our business and have a positive impact on society. We live our purpose in three ways, by supporting healthy living, building thriving communities and caring for our planet.

 

Tate & Lyle is listed on the London Stock Exchange under the symbol TATE.L. American Depositary Receipts trade under TATYY. In the year ended 31 March 2021, Tate & Lyle's revenue from continuing operations totaled £1.2 billion.  For more information, please visit http://www.tateandlyle.com or follow Tate & Lyle on Twitter or LinkedIn.

 

Tate & Lyle's LEI number is: 2138008K14474WPKZ244

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FURFIFSRESIVIIF

Last news